Gulabrao Dagadu Patil

Title: Gulabrao Dagadu Patil: Innovator in Pharmaceutical Synthesis

Introduction

Gulabrao Dagadu Patil is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important medicinal compounds. With a total of 2 patents to his name, Patil's work is recognized for its innovative approaches to drug synthesis.

Latest Patents

Patil's latest patents focus on the synthesis of Raltegravir, an antiretroviral medication used to treat HIV. The first patent describes a novel synthetic route for the preparation of Raltegravir and its pharmaceutically acceptable salts, starting from 2-amino-2-methylpropanenitrile and oxadiazole carbonyl chloride. This process involves the formation of a pyrimidinone intermediate, which is crucial for the final product. The second patent reiterates this innovative synthetic route, emphasizing its significance in pharmaceutical applications.

Career Highlights

Gulabrao Dagadu Patil is currently associated with Emcure Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Emcure has allowed him to focus on developing new synthetic methods that enhance the efficiency and effectiveness of drug production. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Patil has collaborated with several talented individuals in his field, including Mukund Keshav Gurjar and Swapnil Panditrao Sonawane. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Gulabrao Dagadu Patil's work in pharmaceutical synthesis exemplifies the impact of innovative thinking in medicine. His patents not only contribute to the scientific community but also pave the way for advancements in drug development. His dedication to improving pharmaceutical processes continues to inspire future innovations in the field.